Cargando…
Aberrant immunoexpression of p53 tumour-suppressor and Bcl-2 family proteins (Bcl-2 and Bax) in ameloblastomas and odontogenic keratocysts
BACKGROUND: The growth of ameloblastomas (odontogenic tumours) and odontogenic keratocyst (OKC) (developmental cyst) is associated with the expression of proteins related to cell survival and apoptosis. Bcl-2-associated protein X (Bax) and the tumour suppressor protein p53 collectively promote p53-m...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medicina Oral S.L.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9994657/ https://www.ncbi.nlm.nih.gov/pubmed/36911151 http://dx.doi.org/10.4317/jced.59769 |
_version_ | 1784902660076339200 |
---|---|
author | Escobar, Enrico Gómez-Valenzuela, Fernán Peñafiel, Cristian Chimenos-Küstner, Eduardo Pérez-Tomás, Ricardo |
author_facet | Escobar, Enrico Gómez-Valenzuela, Fernán Peñafiel, Cristian Chimenos-Küstner, Eduardo Pérez-Tomás, Ricardo |
author_sort | Escobar, Enrico |
collection | PubMed |
description | BACKGROUND: The growth of ameloblastomas (odontogenic tumours) and odontogenic keratocyst (OKC) (developmental cyst) is associated with the expression of proteins related to cell survival and apoptosis. Bcl-2-associated protein X (Bax) and the tumour suppressor protein p53 collectively promote p53-mediated apoptosis. This study aimed to assess the immunohistochemical expression of p53, Bcl-2 and Bax in conventional ameloblastoma (CA), unicystic ameloblastoma (UA) types, and OKC sporadic (OKC-NS/S) and syndromic (OKC-NBSCC). MATERIAL AND METHODS: Paraffinized blocks of CA (n=18), UA (n=15), OKC-NS/S (n=18) and OKC-NBSCC (n=15) fixed in 10% formalin were used. After diagnosis, tissue specimens were stained by immunohistochemistry for p53, Bcl-2 and Bax marker. Stained cells were randomly counted in five high power fields. The data analysis was performed via Shapiro-Wilk test, ANOVA with Tukey’s multiple comparisons or Kruskal-Wallis with Dunn’s multiple comparisons. Statistical significance was defined as p<0.05. RESULTS: We did not observe differences between p53 expression in CA, mural UA (MUA), intraluminal/luminal UA (I/LUA), OKC-NS/S, and OKC-NBSCC (19.69%, 18.74%, 16.76%, 12.35% and 9.04%, respectively). Similar results were recognized for Bax expression in CA, MUA, I/LUA, OKC-NS/S, and OKC-NBSCC (33.72%, 34.95%, 22.94, 21.58% and 20.76%, respectively). However, we recognized significant differences between Bcl-2 expression in OKC-NS/S vs MUA, OKC-NS/S vs I/LUA, OKC-NS/S vs CA, OKC-NBSCC vs MUA, OKC-NBSCC vs I/LUA, and I/LUA vs CA. P53, Bcl-2 and Bax levels were higher in mural morphological areas versus intraluminal and luminal morphological areas in UA. CONCLUSIONS: There is a tendency for an increased expression of p53, Bcl-2, and Bax proteins in CA, and mural proliferation of UA, compared to lesions with a cystic morphology, which could be associated with a local aggressive behaviour. Key words:p53, Bcl-2, Bax protein, apoptosis, odontogenic tumour, odontogenic cyst. |
format | Online Article Text |
id | pubmed-9994657 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Medicina Oral S.L. |
record_format | MEDLINE/PubMed |
spelling | pubmed-99946572023-03-09 Aberrant immunoexpression of p53 tumour-suppressor and Bcl-2 family proteins (Bcl-2 and Bax) in ameloblastomas and odontogenic keratocysts Escobar, Enrico Gómez-Valenzuela, Fernán Peñafiel, Cristian Chimenos-Küstner, Eduardo Pérez-Tomás, Ricardo J Clin Exp Dent Research BACKGROUND: The growth of ameloblastomas (odontogenic tumours) and odontogenic keratocyst (OKC) (developmental cyst) is associated with the expression of proteins related to cell survival and apoptosis. Bcl-2-associated protein X (Bax) and the tumour suppressor protein p53 collectively promote p53-mediated apoptosis. This study aimed to assess the immunohistochemical expression of p53, Bcl-2 and Bax in conventional ameloblastoma (CA), unicystic ameloblastoma (UA) types, and OKC sporadic (OKC-NS/S) and syndromic (OKC-NBSCC). MATERIAL AND METHODS: Paraffinized blocks of CA (n=18), UA (n=15), OKC-NS/S (n=18) and OKC-NBSCC (n=15) fixed in 10% formalin were used. After diagnosis, tissue specimens were stained by immunohistochemistry for p53, Bcl-2 and Bax marker. Stained cells were randomly counted in five high power fields. The data analysis was performed via Shapiro-Wilk test, ANOVA with Tukey’s multiple comparisons or Kruskal-Wallis with Dunn’s multiple comparisons. Statistical significance was defined as p<0.05. RESULTS: We did not observe differences between p53 expression in CA, mural UA (MUA), intraluminal/luminal UA (I/LUA), OKC-NS/S, and OKC-NBSCC (19.69%, 18.74%, 16.76%, 12.35% and 9.04%, respectively). Similar results were recognized for Bax expression in CA, MUA, I/LUA, OKC-NS/S, and OKC-NBSCC (33.72%, 34.95%, 22.94, 21.58% and 20.76%, respectively). However, we recognized significant differences between Bcl-2 expression in OKC-NS/S vs MUA, OKC-NS/S vs I/LUA, OKC-NS/S vs CA, OKC-NBSCC vs MUA, OKC-NBSCC vs I/LUA, and I/LUA vs CA. P53, Bcl-2 and Bax levels were higher in mural morphological areas versus intraluminal and luminal morphological areas in UA. CONCLUSIONS: There is a tendency for an increased expression of p53, Bcl-2, and Bax proteins in CA, and mural proliferation of UA, compared to lesions with a cystic morphology, which could be associated with a local aggressive behaviour. Key words:p53, Bcl-2, Bax protein, apoptosis, odontogenic tumour, odontogenic cyst. Medicina Oral S.L. 2023-02-01 /pmc/articles/PMC9994657/ /pubmed/36911151 http://dx.doi.org/10.4317/jced.59769 Text en Copyright: © 2023 Medicina Oral S.L. https://creativecommons.org/licenses/by/2.5/This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Escobar, Enrico Gómez-Valenzuela, Fernán Peñafiel, Cristian Chimenos-Küstner, Eduardo Pérez-Tomás, Ricardo Aberrant immunoexpression of p53 tumour-suppressor and Bcl-2 family proteins (Bcl-2 and Bax) in ameloblastomas and odontogenic keratocysts |
title | Aberrant immunoexpression of p53 tumour-suppressor and Bcl-2 family proteins (Bcl-2 and Bax) in ameloblastomas and odontogenic keratocysts |
title_full | Aberrant immunoexpression of p53 tumour-suppressor and Bcl-2 family proteins (Bcl-2 and Bax) in ameloblastomas and odontogenic keratocysts |
title_fullStr | Aberrant immunoexpression of p53 tumour-suppressor and Bcl-2 family proteins (Bcl-2 and Bax) in ameloblastomas and odontogenic keratocysts |
title_full_unstemmed | Aberrant immunoexpression of p53 tumour-suppressor and Bcl-2 family proteins (Bcl-2 and Bax) in ameloblastomas and odontogenic keratocysts |
title_short | Aberrant immunoexpression of p53 tumour-suppressor and Bcl-2 family proteins (Bcl-2 and Bax) in ameloblastomas and odontogenic keratocysts |
title_sort | aberrant immunoexpression of p53 tumour-suppressor and bcl-2 family proteins (bcl-2 and bax) in ameloblastomas and odontogenic keratocysts |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9994657/ https://www.ncbi.nlm.nih.gov/pubmed/36911151 http://dx.doi.org/10.4317/jced.59769 |
work_keys_str_mv | AT escobarenrico aberrantimmunoexpressionofp53tumoursuppressorandbcl2familyproteinsbcl2andbaxinameloblastomasandodontogenickeratocysts AT gomezvalenzuelafernan aberrantimmunoexpressionofp53tumoursuppressorandbcl2familyproteinsbcl2andbaxinameloblastomasandodontogenickeratocysts AT penafielcristian aberrantimmunoexpressionofp53tumoursuppressorandbcl2familyproteinsbcl2andbaxinameloblastomasandodontogenickeratocysts AT chimenoskustnereduardo aberrantimmunoexpressionofp53tumoursuppressorandbcl2familyproteinsbcl2andbaxinameloblastomasandodontogenickeratocysts AT pereztomasricardo aberrantimmunoexpressionofp53tumoursuppressorandbcl2familyproteinsbcl2andbaxinameloblastomasandodontogenickeratocysts |